FDA DTC Study Aims To Fool Consumers, But Not Doctors, In Use Of Fictitious Drug

Study examining design of print advertisements will be straightforward with doctors that a fictitious drug is being presented, while the wording for consumers will be ambiguous.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet